Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: patron_anejo_por_favor who wrote (106173)	6/3/2001 3:15:52 AM
From: patron_anejo_por_favor	Read Replies (1) \| Respond to of 436258

HO HO HO! They should put this stuff in the water cooler at all Schwab and Ameritrade offices: lasvegassun.com June 01, 2001 Study finds drug helps control gambling behavior A University of Minnesota study has found a drug used for treatment of alcohol and bulimia may be useful in helping to control problem gambling behavior. Seventy-five percent of problem gamblers treated with the drug naltrexone reported a reduction in their urge to gamble, the clinical study found. Naltrexone acts on brain areas that process pleasure and urges, and the study's lead investigator, Dr. Suck Won Kim, theorizes the drug could be effective in the treatment of problem gambling. Results of the study were published in today's issue of Biological Psychiatry. The study was funded by a $54,000 grant from the National Center for Responsible Gaming, based in Kansas City